Polyclonal outbreak of vancomycin-resistant enterococcus faecium in a pediatric oncology department

Journal of Pediatric Hematology/Oncology

Volumn 34, Issue 7, 2012, Pages 511-516

  Iosifidis, Elias ^a   Karakoula, Konstantina ^b   Protonotariou, Efthimia ^b   Kaperoni, Maria ^b   Matapa, Eleftheria ^b   Pournaras, Spyros ^c   Koliouskas, Dimitrios ^b   Sofianou, Danai ^b   Roilides, Emmanuel ^a,b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Aristotle University of Thessaloniki   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

Author keywords

colonization; glycopeptides; outbreak; pediatric oncology; vancomycin resistant Enterococcus

Indexed keywords

CARBAPENEM; CEPHALOSPORIN; CLINDAMYCIN; DAPTOMYCIN; GLYCOPEPTIDE; LINEZOLID; METRONIDAZOLE; TEICOPLANIN; VANCOMYCIN;

ADOLESCENT; ARTICLE; BACTERIAL COLONIZATION; BLOODSTREAM INFECTION; CASE CONTROL STUDY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; ENTEROCOCCUS FAECIUM; FEMALE; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFANT; INFECTION CONTROL; MALE; ONCOLOGY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; SCHOOL CHILD; VANCOMYCIN RESISTANT ENTEROCOCCUS;

CASE-CONTROL STUDIES; CHILD; CROSS INFECTION; DISEASE OUTBREAKS; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MEDICAL ONCOLOGY; RETROSPECTIVE STUDIES; VANCOMYCIN RESISTANCE;

EID: 84866889161     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318257a5d3     Document Type: Article

References (26)

1. Leclercq R, Derlot E, Duval J, et al. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988;319:157-161.
2. Pournaras S, Iosifidis E, Roilides E. Advances in antibacterial therapy against emerging bacterial pathogens. Semin Hematol. 2009;46:198-211.
3. Bagga B, Shenep JL. Management of infections caused by vancomycin-resistant gram-positive bacteria. Pediatr Infect Dis J. 2010;29:662-664.
4. Suntharam N, Lankford MG, Trick WE, et al. Risk factors for acquisition of vancomycin-resistant enterococci among hema-tology-oncology patients. Diagn Microbiol Infect Dis. 2002; 43:183-188.
5. Carretto E, Barbarini D, Locatelli F, et al. Vancomycin-resistant Enterococcus faecium infection in three children given allogeneic hematopoietic stem cell transplantation: clinical and microbiologic features. Haematologica. 2000;85:1158-1164.
6. Patel R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother. 2003;51(suppl 3):iii13-iii21.
7. Matar MJ, Tarrand J, Raad I, et al. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control. 2006;34:534-536.
8. Tsiatis AC, Manes B, Calder C, et al. Incidence and clinical complications of vancomycin-resistant Enterococcus in pedia-tric stem cell transplant patients. Bone Marrow Transplant. 2004;33:937-941.
9. Nolan SM, Gerber JS, Zaoutis T, et al. Outbreak of vancomycin-resistant Enterococcus colonization among pedia-tric oncology patients. Infect Control Hosp Epidemiol. 2009; 30:338-345.
10. Schuster F, Graubner UB, Schmid I, et al. Vancomycin-resistant- enterococci\colonization of 24 patients on a pedia-tric oncology unit. Klin Padiatr. 1998;210:261-263.
11. Henning KJ, Delencastre H, Eagan J, et al. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J. 1996;15:848-854.
12. Nourse C, Byrne C, Murphy H, et al. Eradication of vancomycin resistant Enterococcus faecium from a paediatric oncology unit and prevalence of colonization in hospitalized and community-based children. Epidemiol Infect. 2000;124: 53-59.
13. Nourse C, Murphy H, Byrne C, et al. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation. Eur J Pediatr. 1998;157:20-27.
14. Singh-Naz N, Sleemi A, Pikis A, et al. Vancomycin-resistant Enterococcus faecium colonization in children. J Clin Micro-biol. 1999;37:413-416.
15. Woodford N, Stigter JM. Molecular investigation of glycopep-tide resistance in gram-positive bacteria. In: Woodford N, Johnson AP, eds. Molecular Bacteriology. Totowa, NJ: Humana Press; 1998:579-615.
16. Morrison D, Woodford N, Barrett SP, et al. DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains. J Clin Microbiol. 1999;37:1084-1091.
17. Sakka V, Tsiodras S, Galani L, et al. Risk-factors and predictors of mortality in patients colonised with vancomy-cin-resistant enterococci. Clin Microbiol Infect. 2008;14:14-21.
18. Byers KE, Anglim AM, Anneski CJ, et al. A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol. 2001;22:140-147.
19. Bonten MJ, Slaughter S, Ambergen AW, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med. 1998;158:1127-1132.
20. Kosack A, Riedel E, Kiehn TE, et al. Vancomycin-resistant Enterococcus in pediatric oncology patients: an analysis of potential consequences of colonization and infection. Pediatr Blood Cancer. 2009;52:300-302.
21. Zaas AK, Song X, Tucker P, et al. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis. 2002; 35:1139-1146.
22. Garbutt JM, Ventrapragada M, Littenberg B, et al. Association between resistance to vancomycin and death in cases of Enter-ococcus faecium bacteremia. Clin Infect Dis. 2000;30:466-472.
23. Haas EJ, Zaoutis TE, Prasad P, et al. Risk factors and outcomes for vancomycin-resistant Enterococcus bloodstream infection in children. Infect Control Hosp Epidemiol. 2010; 31:1038-1042.
24. Siegel JD, Rhinehart E, Jackson M, et al. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35:S165-S193.
25. Perencevich EN, Fisman DN, Lipsitch M, et al. Projected benefits of active surveillance for vancomycin-resistant enter-ococci in intensive care units. Clin Infect Dis. 2004;38:1108-1115.
26. de Bruin MA, Riley LW. Does vancomycin prescribing intervention affect vancomycin-resistant Enterococcus infection and colonization in hospitals? A systematic review. BMC Infect Dis. 2007;7:24.